These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29325469)
1. Current update of a thermosensitive liposomes composed of DPPC and Brij78. Ho L; Bokharaei M; Li SD J Drug Target; 2018; 26(5-6):407-419. PubMed ID: 29325469 [TBL] [Abstract][Full Text] [Related]
2. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149 [TBL] [Abstract][Full Text] [Related]
3. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. Tagami T; May JP; Ernsting MJ; Li SD J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351 [TBL] [Abstract][Full Text] [Related]
4. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635 [TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response. Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464 [TBL] [Abstract][Full Text] [Related]
6. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980 [TBL] [Abstract][Full Text] [Related]
8. Size of thermosensitive liposomes influences content release. Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921 [TBL] [Abstract][Full Text] [Related]
9. Inhomogeneous crystal grain formation in DPPC-DSPC based thermosensitive liposomes determines content release kinetics. Lu T; Ten Hagen TLM J Control Release; 2017 Feb; 247():64-72. PubMed ID: 28042084 [TBL] [Abstract][Full Text] [Related]
10. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor. Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394 [TBL] [Abstract][Full Text] [Related]
11. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639 [TBL] [Abstract][Full Text] [Related]
12. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration. Tagami T; Kubota M; Ozeki T J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287 [TBL] [Abstract][Full Text] [Related]
13. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. May JP; Ernsting MJ; Undzys E; Li SD Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292 [TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Unezaki S; Maruyama K; Takahashi N; Koyama M; Yuda T; Suginaka A; Iwatsuru M Pharm Res; 1994 Aug; 11(8):1180-5. PubMed ID: 7971721 [TBL] [Abstract][Full Text] [Related]
15. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant. Song H; Zhang J; Liu X; Deng T; Yao P; Zhou S; Yan W Pharm Dev Technol; 2016 Sep; 21(6):680-7. PubMed ID: 25975585 [TBL] [Abstract][Full Text] [Related]
16. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes. Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158 [TBL] [Abstract][Full Text] [Related]
17. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073 [TBL] [Abstract][Full Text] [Related]
18. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Hossann M; Wiggenhorn M; Schwerdt A; Wachholz K; Teichert N; Eibl H; Issels RD; Lindner LH Biochim Biophys Acta; 2007 Oct; 1768(10):2491-9. PubMed ID: 17618599 [TBL] [Abstract][Full Text] [Related]
19. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227 [TBL] [Abstract][Full Text] [Related]
20. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. Banno B; Ickenstein LM; Chiu GN; Bally MB; Thewalt J; Brief E; Wasan EK J Pharm Sci; 2010 May; 99(5):2295-308. PubMed ID: 19902527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]